Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
1999-11-30
2008-10-21
Kim, Jennifer (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S258100, C514S365000, C514S369000
Reexamination Certificate
active
07439248
ABSTRACT:
The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as active ingredient.
REFERENCES:
patent: 4280997 (1981-07-01), Van Leverink
patent: 5532256 (1996-07-01), Malamas et al.
patent: 5972970 (1999-10-01), Sohda et al.
patent: 6710050 (2004-03-01), Weibel et al.
patent: 6866867 (2005-03-01), Staniforth et al.
patent: 0 945 134 (1999-09-01), None
patent: WO 92/17161 (1992-10-01), None
patent: WO 95/06461 (1995-03-01), None
patent: WO 96/18386 (1996-06-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/45291 (1998-10-01), None
patent: WO 2006002255 (2005-06-01), None
patent: WO 2006002255 (2005-06-01), None
Hjorth Thyge Borup
Weibel Helle
Dority & Manning P.A.
Dr. Reddy's Laboratories Inc.
Dr. Reddy's Laboratories Limited
Kim Jennifer
LandOfFree
Pharmaceutical composition and the process for its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition and the process for its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and the process for its preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4008975